SCHEMBL4533322

SCHEMBL4533322

COc1ccc(C(=O)NC(O)Cc2ccc(C(=O)Nc3ccccc3NC(=O)OC(C)(C)C)cc2)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
NPSR1 Q6W5P4 1/20 0.51
PDE4D Q08499 1/20 0.50
CHEK1 O14757 1/20 0.49
PIM1 P11309 1/20 0.49
MAPK8 P45983 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
HDAC1 Q13547 4/20 0.47
HDAC2 Q92769 2/20 0.47
PKM P14618 1/20 0.47
NR1H4 Q96RI1 1/20 0.46
POLB P06746 2/20 0.44
KDM4E B2RXH2 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1064496 0.84 ALDH1A1 (0.51) ALDH1A1NPSR1PDE4DCHEK1PIM1
SCHEMBL6188703 0.83 HDAC1 (0.52) HDAC1HDAC2NR1H4KMT2AMAPT
SCHEMBL8349561 0.82 ROCK2 (0.49) ALDH1A1NPSR1PDE4DCHEK1PIM1
SCHEMBL1064879 0.80 HDAC1 (0.73) NPSR1HDAC1HDAC2NR1H4MAPT
SCHEMBL11244161 0.76 PDE4D (0.81) ALDH1A1NPSR1PDE4DCHEK1PIM1
SCHEMBL1064323 0.75 HDAC1 (0.53) ALDH1A1HDAC1NR1H4KMT2AMAPT
SCHEMBL2732298 0.75 HDAC1 (0.53) ALDH1A1HDAC1HDAC2NR1H4KMT2A
SCHEMBL30944730 0.75 HDAC1 (0.53) ALDH1A1HDAC1NR1H4KMT2AMAPT
SCHEMBL3663495 0.74 HDAC1 (0.52) ALDH1A1HDAC1NR1H4KMT2AMAPT
SCHEMBL1435144 0.74 HDAC1 (0.54) HDAC1KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595343-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2009-09-29 US disclosed
US-20040106599-A1 Inhibitors of histone deacetylase 92229129 QUEBEC INC. (CA) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106599-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 ALDH1A1 796/4885NPSR1 4455/4885PDE4D 2837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.